Vixiar Medical, Inc., a Baltimore, Maryland-based company dedicated to the development of non-invasive devices and systems for monitoring cardiopulmonary diseases has raised $1.5 million from new and existing investors. New investors joining in this round included Emerald Development Managers, MMG Opportunities and several individual investors. Existing investors included The Maryland Technology Development Corporation (TEDCO) through its seed fund, the Abell Foundation, individual investors and
Read More
Northwestern Medicine and Eko Launches AI Algorithms Heart Murmurs Study
Northwestern Medicine and Eko launches a new clinical study to validate algorithms that help providers more accurately screen for valvular heart disease with a digital stethoscopeToday Northwestern Medicine Bluhm Cardiovascular Institute and Eko have announced a partnership pioneering the use of artificial intelligence (AI) for cardiac screening in a new study of Eko’s cardiac monitoring platform. The study aims to demonstrate that Eko’s digital stethoscopes and AI algorithms can interpret heart
Read More
Ochsner to Deliver Remote Monitoring Service to Cardiac Implant Patients Across Southeast
Ochsner Health System announced it will deliver remote monitoring service for patients with cardiac implants will be utilized in the throughout Louisiana, Arkansas, Mississippi, Alabama, and Georgia. The provider has signed an agreement with Geneva Health Solutions (GHS), a device data management platform and remote monitoring service for implantable cardiac devices to provide the service. The GHS system will drive full automated scheduling and reporting in collaboration with Ochsner’s Epic
Read More
Eko’s AI Algorithm Detects Pediatric Heart Murmurs With Cardiologist-Level Accuracy
Eko’s heart murmur detection AI-driven algorithm outperformed four out of five cardiologists for the detection of heart murmurs in a recent clinical study.During the American Heart Association’s Scientific Sessions 2018, Eko, a cardiac monitoring company that combines non-invasive sensors with machine learning presented a clinical study abstract revealing their murmur detection algorithm outperformed the majority of participating cardiologists. The study entitled, “Artificial Intelligence
Read More
AliveCor Receives “Breakthrough Device” Designation from FDA for Bloodless Hyperkalemia Test
AliveCor, a Mountain View, CA-based digital health startup developing solutions to transform cardiac care, announced on Monday received “breakthrough device” designation from the U.S. Food and Drug Administration for their bloodless hyperkalemia test. Developed with Mayo Clinic, AliveCor’s KardiaK Platform screens for elevated levels of blood potassium – hyperkalemia, without requiring any blood from the patient.This designation signals that the FDA will consider the technology on an
Read More
Biotricity Releases Mobile Cardiac Telemetry Solution
Biotricity today announced the commercial availability of Bioflux, a real-time, high-precision mobile cardiac telemetry solution for customers. The Bioflux system, which received final FDA approval in December, is a complete solution for cardiac monitoring and diagnosis, consisting of the Bioflux device, proprietary software, and a 24/7 monitoring center that merges seamlessly with physicians’ existing platforms and workflows.The Bioflux system is a complete solution for cardiac monitoring and
Read More
Cardiac Monitoring Startup Eko Devices Raises $5M to Bring Intelligence to Heart Sounds
Eko, a San Francisco, CA-based platform of non-invasive cardiac screening devices, care coordination software, and machine learning algorithms has raised $5 million in Series A funding led by ARTIS Ventures. The round also included participation from Strategic Partners, Dreamlt Ventures, 1812 Ventures, and FOUNDER.org. Eko plans to utilize the funding to accelerate its commercial team and to expand clinical studies on the use of Eko's platform for valvular heart disease screening and heart
Read More
Cardiac Insight Lands $2.5M for Portable, Hand-held ECG Device
Cardiac Insight, a University of Washington spinoff focused on developing advanced body-worn sensing for diagnostic testing in cardiology has raised $2.5 million in Series C funding. The company will utilize the funding to accelerate the market penetration of it's CardeaScreen™ product as well as finalize the development of the company’s proprietary wearable sensor technology.Cardea’s flagship product is the CardeaScreen, is a 12-lead electrocardiogram (ECG) exam that helps identify young
Read More
FDA Approves Medtronic’s Remote Monitoring Pacemaker App
The U.S. Food and Drug Administration (FDA) has cleared approval and U.S. commercial availability of Medtronic's MyCareLink Smart(TM) Monitor, an app-based remote monitoring system for patients with implantable pacemakers. The app-based system makes it easy for heart device patients to stay connected to their doctor.
How It Works
Prescribed by a physician, The MyCareLink Smart Monitor is comprised of a handheld portable device reader and the MyCareLink Smart mobile app, available for free on
Read More